PuSH - Publikationsserver des Helmholtz Zentrums München

Shekhar, A.* ; Di Lucrezia, R.* ; Jerye, K.* ; Korotkov, V.S.* ; Harmrolfs, K.* ; Rox, K.* ; Weich, H.A.* ; Ghai, I.* ; Delhommel, F. ; Becher, I.* ; Degenhart, C.* ; Fansa, E.* ; Unger, A.* ; Habenberger, P.* ; Klebl, B.* ; Lukat, P.* ; Schmelz, S.* ; Henke, S.* ; Borgert, S.* ; Lang, J.C.* ; Sasse, F.* ; Diestel, R.* ; Richter, C.* ; Schneider-Daum, N.* ; Hinkelmann, B.* ; Niemz, J.* ; Lehr, C.M.* ; Jänsch, L.* ; Huehn, J.* ; Alm, R.* ; Savitski, M.M.* ; Welte, T.* ; Hesterkamp, T.* ; Sattler, M. ; Winterhalter, M.* ; Blankenfeldt, W.* ; Medina, E.* ; Bilitewski, U.* ; Dinkel, K.* ; Brönstrup, M.*

Highly potent quinoxalinediones inhibit α-hemolysin and ameliorate Staphylococcus aureus lung infections.

Cell Host Microbe 33, 560-572.e21 (2025)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold (Paid Option)
Creative Commons Lizenzvertrag
Hospital-acquired pneumonia caused by Staphylococcus aureus is associated with patient morbidity and mortality, despite adequate antibiotic therapy. This illustrates the need for treatments beyond antibiotics. The pore-forming heptameric toxin α-hemolysin (Hla) is a major pathogenicity factor of S. aureus and a clinically validated target. We identify quinoxalinediones (QDS) as highly potent Hla inhibitors, conferring protection against the hallmarks of Hla-induced pathogenicity such as Ca2+ influx, cytotoxicity, hemolysis, and monolayer destruction. The effects were exerted across major Hla subtypes in all relevant cell types. QDS prevented the formation of functional pores by interacting with Hla near the phospholipid-binding site. The QDS analog, H052, was active in mouse models of S. aureus lung infections, when administered prophylactically or therapeutically, either as monotherapy or when given in combination with the antibiotic linezolid. The study provides evidence that complex bacterial toxins can be targeted in vivo by drug-like small molecules.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Staphylococcus Aureus ; Antibacterials ; Drug Discovery ; Lung Infections ; Mechanism Of Action ; Toxin Inhibition ; Virulence Inhibitors; Alpha-hemolysin; Monoclonal-antibody; Escherichia-coli; Nmr-spectroscopy; Pneumonia; Toxin; Expression; Virulence; Prevention; Strategies
ISSN (print) / ISBN 1931-3128
e-ISSN 1934-6069
Zeitschrift Cell Host & Microbe
Quellenangaben Band: 33, Heft: 4, Seiten: 560-572.e21 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort 50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Structural Biology (STB)
Förderungen
Drug Discovery and Cheminformatics for New Anti-Infectives" (iCA)
German Center for Infection Research
HZI pre-4D fund
Helmholtz Validation Fund